Vericel (US:VCEL)2025-11-06 13:30Financial Performance - Total Q3 revenue reached $67.5 million[6], driven by strong performance across franchises[7] - Gross margin was 73.5%[7] - Net income was $5.1 million[7] - Adjusted EBITDA was $17.0 million, representing a 25% margin[7] - Operating cash flow was $22.1 million[7] - Cash and investments totaled $185 million[7, 13] Product Performance - MACI revenue grew by 25%, achieving a record third-quarter revenue of nearly $56 million[7] - NexoBrid achieved record quarterly revenue[7] - Epicel had its highest revenue quarter of the year[7] Strategic Initiatives - MACI sales force expansion is on track to be completed in Q4, with new hires starting in territories in Q1 2026[7] - The company remains on track to initiate the MACI Ankle study in Q4[7]